文献速递心力衰竭与心肌病心律失常

急性心肌炎的遗传结构及其与遗传性心肌病的重叠

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy.
PubMed 文献 · Circulation · 2022-09-26

该基于人群的队列纳入336例急性心肌炎患者,靶向测序发现8%携带致病性DCM/ACM相关变异,显著高于健康对照的<1%(P=0.0097)。伦敦队列富集ACM基因截短变异(3.1% vs 0.4%,OR 8.2),马斯特里赫特队列富集DCM基因截短变异(7% vs 1%,OR 3.6)。中位随访5.0年全因死亡率5.4%,基因阳性者5年死亡风险11.1% vs 基因阴性3.3%(Padjusted=0.08)。

要点

  • 急性心肌炎患者中8%携带DCM或ACM相关致病性变异,健康对照<1%。
  • 左室射血分数正常者以DSP截短变异为主,降低者以TTN截短变异为主。
  • 建议急性心肌炎患者考虑遗传咨询和检测以指导管理及家系筛查。

核心结论

  • 急性心肌炎患者中8%携带DCM或ACM相关遗传变异,显著高于健康对照。
  • 这些变异以DSP-tv(左室射血分数正常伴室性心律失常)和TTN-tv(左室射血分数降低)为主,对治疗、风险分层和家系筛查有临床意义。

研究设计与样本

  • 基于人群的队列研究,纳入伦敦和马斯特里赫特连续336例急性心肌炎患者。
  • 所有参与者接受靶向DNA测序,检测已知心肌病相关基因,并与同平台测序的1053名健康对照比较。
  • 伦敦队列(n=230;中位年龄33岁;84%男性)与英国国家住院数据核对,病例 ascertainment 66%。
  • 马斯特里赫特队列(n=106;中位年龄54岁;61%男性)。
  • 主要结局为全因死亡。

主要发现

  • 若在DCM或ACM患者中视为致病性的变异,在心肌炎病例中检出率为8%,健康对照<1%(P=0.0097)。
  • 伦敦队列中ACM相关基因罕见截短变异富集:病例3.1% vs 对照0.4%(OR 8.2;P=0.001),主要由左室射血分数正常且伴室性心律失常者的DSP-tv驱动。
  • 马斯特里赫特队列中DCM相关基因罕见截短变异富集:7%(均左室射血分数<50%)vs 对照1%(OR 3.6;P=0.0116),主要为TTN-tv。
  • 中位随访5.0年(IQR 3.9-7.8年),全因死亡率5.4%;死亡中三分之二为心血管原因,其中92%归因于心力衰竭恶化,8%为心脏性猝死。
  • 基因阳性患者5年死亡风险11.1%,基因阴性患者3.3%(Padjusted=0.08)。

临床怎么用

  • 对急性心肌炎患者应考虑遗传咨询和基因检测,以识别潜在遗传性心肌病。
  • 基因检测有助于对多数患者进行 reassurance,并对携带变异者优化管理、风险分层和家系筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute myocarditis is an inflammatory condition that may herald the onset of dilated cardiomyopathy (DCM) or arrhythmogenic cardiomyopathy (ACM). We investigated the frequency and clinical consequences of DCM and ACM genetic variants in a population-based cohort of patients with acute myocarditis. METHODS: This was a population-based cohort of 336 consecutive patients with acute myocarditis enrolled in London and Maastricht. All participants underwent targeted DNA sequencing for well-characterized cardiomyopathy-associated genes with comparison to healthy controls (n=1053) sequenced on the same platform. Case ascertainment in England was assessed against national hospital admission data. The primary outcome was all-cause mortality. RESULTS: Variants that would be considered pathogenic if found in a patient with DCM or ACM were identified in 8% of myocarditis cases compared with <1% of healthy controls (P=0.0097). In the London cohort (n=230; median age, 33 years; 84% men), patients were representative of national myocarditis admissions (median age, 32 years; 71% men; 66% case ascertainment), and there was enrichment of rare truncating variants (tv) in ACM-associated genes (3.1% of cases versus 0.4% of controls; odds ratio, 8.2; P=0.001). This was driven predominantly by DSP-tv in patients with normal LV ejection fraction and ventricular arrhythmia. In Maastricht (n=106; median age, 54 years; 61% men), there was enrichment of rare truncating variants in DCM-associated genes, particularly TTN-tv, found in 7% (all with left ventricular ejection fraction <50%) compared with 1% in controls (odds ratio, 3.6; P=0.0116). Across both cohorts over a median of 5.0 years (interquartile range, 3.9-7.8 years), all-cause mortality was 5.4%. Two-thirds of deaths were cardiovascular, attributable to worsening heart failure (92%) or sudden cardiac death (8%). The 5-year mortality risk was 3.3% in genotype-negative patients versus 11.1% for genotype-positive patients (Padjusted=0.08). CONCLUSIONS: We identified DCM- or ACM-associated genetic variants in 8% of patients with acute myocarditis. This was dominated by the identification of DSP-tv in those with normal left ventricular ejection fraction and TTN-tv in those with reduced left ventricular ejection fraction. Despite differences between cohorts, these variants have clinical implications for treatment, risk stratification, and family screening. Genetic counseling and testing should be considered in patients with acute myocarditis to help reassure the majority while improving the management of those with an underlying genetic variant.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Lota AS, Hazebroek MR, Theotokis P, et al. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy. Circulation. 2022. PMID: 36154167. doi:10.1161/CIRCULATIONAHA.121.058457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。